Effect of vitamin K 2 pharmaceuticals ( menatetrenone ) for the bone mineral content lowering of the liver cirrhosis and the primary biliary cirrhosis patient.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.